Publication | Closed Access
OP0167 A randomized, double-blind, phase 1 study demonstrates equivalence in pharmacokinetics, safety, and efficacy of CT-P13 and infliximab in patients with ankylosing spondylitis
18
Citations
0
References
2012
Year
No additional data available for this publication yet. Check back later!